Molecules 2010, 15(7), 4670-4678; doi:10.3390/molecules15074670
Review

Ribozyme-Mediated Inhibition of 801-bp Deletion-Mutant Epidermal Growth Factor Receptor mRNA Expression in Glioblastoma Multiforme

Received: 8 June 2010; in revised form: 28 June 2010 / Accepted: 29 June 2010 / Published: 30 June 2010
(This article belongs to the Special Issue Catalytic Nucleic Acids)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The epidermal growth factor receptor (HER1/EGFR) is known to be disregulated in a large subgroup of glioblastoma multiforme cases. Disregulation of HER1/EGFR is related to malignant transformation and tumor growth in various human cancers, including malignant glioma. One mechanism that may lead to disregulated HER1/EGFR signaling is the intrinsic alteration of the receptor structure due to mutational changes. The most common mutant form of HER1/EGFR, named variant III (EGFRvIII), results from an 801 bp in-frame deletion in the DNA sequence encoding the extracellular ligand-binding domain. Independent of ligand–binding, EGFRvIII is constitutively activated and beyond external control. Since its cellular expression was shown to relate enhanced tumorigenicity, various therapeutic strategies were developed to target EGFRvIII, including monoclonal antibodies, vaccination therapies and small-molecule tyrosine kinase inhibitors. In this review, we focus on ribozyme-mediated inhibition of EGFRvIII messenger RNA expression as a gene therapeutic approach for EGFRvIII-expressing glioblastoma multiforme.
Keywords: EGFRvIII; ribozymes; retrovirus-mediated DNA transfer
PDF Full-text Download PDF Full-Text [234 KB, Updated Version, uploaded 18 June 2014 19:33 CEST]
The original version is still available [234 KB, uploaded 18 June 2014 19:33 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Karpel-Massler, G.; Wirtz, C.R.; Halatsch, M.-E. Ribozyme-Mediated Inhibition of 801-bp Deletion-Mutant Epidermal Growth Factor Receptor mRNA Expression in Glioblastoma Multiforme. Molecules 2010, 15, 4670-4678.

AMA Style

Karpel-Massler G, Wirtz CR, Halatsch M-E. Ribozyme-Mediated Inhibition of 801-bp Deletion-Mutant Epidermal Growth Factor Receptor mRNA Expression in Glioblastoma Multiforme. Molecules. 2010; 15(7):4670-4678.

Chicago/Turabian Style

Karpel-Massler, Georg; Wirtz, Christian Rainer; Halatsch, Marc-Eric. 2010. "Ribozyme-Mediated Inhibition of 801-bp Deletion-Mutant Epidermal Growth Factor Receptor mRNA Expression in Glioblastoma Multiforme." Molecules 15, no. 7: 4670-4678.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert